Menu
Back to Journals » Blood and Lymphatic Cancer: Targets and Therapy » Volume 14
ESCI
Impact Factor
Blood and Lymphatic Cancer: Targets and Therapy
ISSN: 1179-9889
- View all (103)
- Volume 14, 2024 (2)
- Volume 13, 2023 (7)
- Volume 12, 2022 (12)
- Volume 11, 2021 (6)
- Volume 10, 2020 (2)
- Volume 9, 2019 (7)
- Volume 8, 2018 (7)
- Volume 7, 2017 (8)
- Volume 6, 2016 (5)
- Volume 5, 2015 (11)
- Volume 4, 2014 (13)
- Volume 3, 2013 (6)
- Volume 2, 2012 (12)
- Volume 1, 2011 (5)
Archive: Volume 14, 2024
Original Research
AC024896.1/miR-363-3p Axis Regulates the Malignant Progression of Acute Myeloid Leukemia by Cuproptosis-Related Gene MYO1B
Zhang J, Zheng Y, Liu H, Liu B
Blood and Lymphatic Cancer: Targets and Therapy 2024, 14:17-30
Published Date: 24 March 2024
Review
Refractory Burkitt Lymphoma: Diagnosis and Interventional Strategies
Malfona F, Testi AM, Chiaretti S, Moleti ML
Blood and Lymphatic Cancer: Targets and Therapy 2024, 14:1-15
Published Date: 13 March 2024